genedrive (LON:GDR) Trading Down 8% – Should You Sell?

genedrive plc (LON:GDRGet Free Report) shares fell 8% during trading on Tuesday . The stock traded as low as GBX 2.25 ($0.03) and last traded at GBX 2.30 ($0.03). 1,411,990 shares were traded during mid-day trading, a decline of 89% from the average session volume of 13,075,102 shares. The stock had previously closed at GBX 2.50 ($0.03).

genedrive Stock Down 8.0 %

The company has a debt-to-equity ratio of 8.57, a quick ratio of 5.52 and a current ratio of 1.63. The firm has a market capitalization of £12.49 million, a P/E ratio of -57.48 and a beta of -0.04. The stock has a fifty day moving average price of GBX 2.29 and a two-hundred day moving average price of GBX 2.43.

Insider Buying and Selling at genedrive

In related news, insider Ian David Gilham bought 225,000 shares of the firm’s stock in a transaction on Friday, December 20th. The stock was bought at an average cost of GBX 2 ($0.03) per share, for a total transaction of £4,500 ($5,644.05). 14.75% of the stock is owned by insiders.

About genedrive

(Get Free Report)

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.

Recommended Stories

Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.